Hepatocellular carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Patients with CNLC-Ia, Ib, IIa/BCLC-A stage hepatocellular carcinoma; Or other stages that are deemed suitable for one-stage resection after multidisciplinary evaluation; ? Liver function classification Child Pugh A; ? ECOG-PS 0 or 1 point; ? ICG-R15<30%; ? 18-75 years old; ? Sign the informed consent form and agree to participate in the clinical study.
Exclusion criteria
Exclusion criteria: ? Individuals at risk of severe portal hypertension or esophageal and gastric variceal bleeding Those who are unwilling to undergo laparoscopic surgery or participate in clinical trials Patients with concurrent malignant tumor diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compliance rate of portal vein territory-based anatomic hepatectomy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative liver dysfunction;operative time;blood loss during operation;complication;Progression free survival (PFS) One year postoperative ;Recurrence free survival (RFS) One year postoperative ; | — |
Countries
China
Contacts
Air Force Medical Center of PLA